Skip to main content

Table 2 Anthropometric and clinical data of control subjects and individuals with DKD categorized according to the estimated glomerular filtration rate (eGFR; mL/min/1.73ā€‰m2) and albumin excretion rate (AER; A1ā€‰=ā€‰normoalbuminuria, A2ā€‰=ā€‰microalbuminuria; A3ā€‰=ā€‰macroalbuminuria)

From: Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis

Ā 

Control eGFRā€‰>ā€‰60

DKDĀ eGFRā€‰>ā€‰60 A1ā€‰+ā€‰A2

DKDĀ eGFRā€‰<ā€‰60 A3

n (F/M)

8 (4/4)

10 (7/3)

25 (7/18)

Age (years)

68.5 (58ā€“84)

68 (53ā€“75)

69 (55ā€“87)

eGFR (mL/min/1.73m2)

84.5 (63ā€“102)

82.0 (61ā€“131)

25 (10ā€“46)#

AER (mg/g creatinine)

ā€“

9.5 (2.4ā€“114)

1128 (317ā€“6430)@

Time of DM (years)

ā€“

14 (4ā€“26)

18 (6ā€“30)

CVD history (%)

ā€“

2 (20%)

11 (44%)

BMI (kg/m2)

24.9 (21ā€“29)

33 (25ā€“45) *

27 (21ā€“38)

HbA1c (%)

5.6 (5.0ā€“6.0)

8.4 (7.0ā€“8.0)#

8.3 (6.0ā€“10.0) #

Fructosamine (Ī¼mol/L)

219 (205ā€“262)

308 (158ā€“428)&

331 (329ā€“506) &

TC (mg/dL)

208 (155ā€“290)

144 (114ā€“186)$

154 (92ā€“313)

TG (mg/dL)

111 (71ā€“362)

88 (64ā€“151)

148 (78ā€“329)

HDLc (mg/dL)

49 (33ā€“87)

46 (35ā€“92)

40 (21ā€“140)

CML (Ī¼g/mL)

0.5 (0.3ā€“1.0)

1.7 (0.5ā€“3.4)

1.0 (0.7ā€“7.3)

  1. BMI body mass index, HbA1c glycated hemoglobin, TC total cholesterol, TG triglycerides, HDLc HDL cholesterol, CML carboxymethyl-lysine. Results were compared by the Kruskal-Wallis test with Holm-Sidak posttest (median - range); * pā€‰<ā€‰0.004; # pā€‰<ā€‰0.0001; & pā€‰<ā€‰0.001 and $ pā€‰<ā€‰0.006 in comparison to Control GFRā€‰>ā€‰60, and by Mann- Whitney test; @ pā€‰<ā€‰0.001 in comparison to eGFR >ā€‰60 A1ā€‰+ā€‰A2